Tiotropium Respimat® 2.5 mg Add-on to ICS or ICS plus controller medications Improves Lung Function in Adults and Adolescents With Mild, Moderate, or Severe Symptomatic Asthma

被引：0
|
作者：
Berger, William E. [1 ]
Meltzer, Eli O. [2 ]
Unseld, Anna [3 ]
Shaikh, Asif [4 ]
Engel, Michael [5 ]
机构：
[1] Southern Calif Res Ctr, Mission Viejo, CA USA
[2] Allergy & Asthma Med Grp & Res Ctr, San Diego, CA USA
[3] Boehringer Ingelheim Pharma GmbH & Co KG, Global Biometr & Data Sci, Biberach, Germany
[4] Boehringer Ingelheim Pharmaceut Inc, Clin Dev & Data Sci, 90 E Ridge POB 368, Ridgefield, CT 06877 USA
[5] Boehringer Ingelheim Pharma GmbH & Co KG, TA Resp Dis, Ingelheim, Germany
来源：
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2017年 / 139卷 / 02期
关键词：
D O I：
10.1016/j.jaci.2016.12.312
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
302
引用
收藏
页码：AB96 / AB96
页数：1
相关论文
共 50 条
  • [21] ONCE-DAILY TIOTROPIUM RESPIMAT (R) ADD-ON TO AT LEAST ICS IN ADULT PATIENTS WITH SYMPTOMATIC ASTHMA: POOLED SAFETY ANALYSIS
    Dusser, D.
    Buhl, R.
    Castro, M.
    Kerstjens, H. A. M.
    Paggiaro, P.
    Engel, M.
    Moroni-Zentgraf, P.
    Unseld, A.
    Bateman, E. D.
    THORAX, 2015, 70 : A151 - A152
  • [22] Tiotropium Respimat® Add-on to at Least Ics Therapy Demonstrates Reduced Risk of Severe Asthma Exacerbation and Asthma Worsening in Symptomatic Asthma, Independent of IgE or Blood Eosinophil Levels
    Casale, Thomas B.
    Tashkin, Donald P.
    Luehmann, Reinhold
    Engel, Michael
    Moroni-Zentgraf, Petra
    Kerstjens, Huib A. M.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2016, 137 (02) : AB214 - AB214
  • [23] Once-daily tiotropium Respimat® as add-on to at least medium- to high-dose ICS, with or without LABA, improves lung function in patients with symptomatic asthma, independent of allergic status
    Dahl, R.
    Bateman, E. D.
    Casale, T.
    Pizzichini, E.
    Vandewalker, M.
    Virchow, J. C.
    Engel, M.
    Sigmund, R.
    Moroni-Zentgraf, P.
    Kerstjens, H. A. M.
    ALLERGY, 2014, 69 : 515 - 515
  • [24] DIURNAL VARIABILITY IN PEAK EXPIRATORY FLOW WITH TIOTROPIUM RESPIMAT® IN ADULTS WITH SEVERE, MODERATE AND MILD SYMPTOMATIC ASTHMA
    Davies, Huw
    Aalbers, Rene
    Casale, Thomas
    Moroni-Zentgraf, Petra
    Van Hecke, Benjamin
    Sigmund, Ralf
    Kerstjens, Huib
    RESPIROLOGY, 2017, 22 : 9 - 10
  • [25] Once-daily tiotropium respimat add-on to at least ICS maintenance therapy reduces exacerbation risk in patients with uncontrolled symptomatic asthma
    Halpin, David
    Bateman, Eric
    Paggiaro, Pierluigi
    Bleecker, Eugene
    Engel, Michael
    Moroni-Zentgraf, Petra
    Schmidt, Hendrik
    Kerstjens, Huib
    EUROPEAN RESPIRATORY JOURNAL, 2014, 44
  • [26] ONCE-DAILY TIOTROPIUM RESPIMAT® ADD-ON TO AT LEAST ICS MAINTENANCE THERAPY REDUCES EXACERBATION RISK IN PATIENTS WITH UNCONTROLLED SYMPTOMATIC ASTHMA
    Doherty, Dennis E.
    Halpin, David
    Bateman, Eric
    Paggiaro, Pierluigi
    Bleecker, Eugene
    Engel, Michael
    Moroni-Zentgraf, Petra
    Schmidt, Hendrik
    Kerstjens, Huib Am
    RESPIROLOGY, 2015, 20 : 5 - 5
  • [27] Tiotropium Respimat® Add-On Therapy To Inhaled Corticosteroids (ics) plus Long-Acting β2-Agonists (labas) In Patients With Symptomatic Severe Asthma: Efficacy By Level Of Airway Obstruction
    Kerstjens, H. A. M.
    Engel, M.
    Dahl, R.
    Paggiaro, P.
    Beck, E.
    Vandewalker, M.
    Sigmund, R.
    Moroni-Zentgraf, P.
    Bateman, E. D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [28] TIOTROPIUM RESPIMAT® ADD-ON THERAPY TO INHALED CORTICOSTEROIDS (ICS) plus LONG-ACTING β2-AGONISTS (LABAS) IN PATIENTS WITH SYMPTOMATIC SEVERE ASTHMA: EFFICACY BY LEVEL OF AIRWAY OBSTRUCTION
    Frith, P.
    Kerstjens, H.
    Engel, M.
    Dahl, R.
    Paggiaro, P.
    Beck, E.
    Vandewalker, M.
    Sigmund, R.
    Moroni-Zentgraf, P.
    Bateman, E.
    RESPIROLOGY, 2016, 21 : 107 - 107
  • [29] ONCE-DAILY TIOTROPIUM RESPIMAT (R) AS ADD-ON TO AT LEAST MEDIUM- TO HIGH-DOSE ICS, WITH OR WITHOUT LABA, IMPROVES LUNG FUNCTION IN PATIENTS WITH SYMPTOMATIC ASTHMA, INDEPENDENT OF ALLERGIC STATUS
    Dahl, R.
    Casale, T.
    Pizzichini, E.
    Vandewalker, M.
    Virchow, J. C.
    Engel, M.
    Sigmund, R.
    Moroni-Zentgraf, P.
    Kerstjens, H. A. M.
    THORAX, 2014, 69 : A177 - A178
  • [30] 24-HOUR LUNG FUNCTION RESPONSE TO TIOTROPIUM RESPIMAT® ADD-ON TO MAINTENANCE THERAPY IN SYMPTOMATIC PATIENTS WITH MODERATE PERSISTENT ASTHMA.
    Casale, T.
    Carr, W. W.
    Greos, L.
    Engel, M.
    Bour, L. J.
    Moroni-Zentgraf, P.
    Kerstjens, H. A.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2014, 113 (05) : A108 - A108
12345